Skip to main content

Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on April 29, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and older with untreated hypertension, according to a study published online April 21 in Nature Medicine.

Jiang He, M.D., Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues randomly assigned 163 villages in rural China to a nonphysician community health care provider-led intervention and 163 villages to usual care to examine the effectiveness of BP reduction on dementia among 33,995 individuals aged 40 years and older with untreated hypertension. Trained nonphysician community health care providers in the intervention group initiated and titrated antihypertensive medications according to a simple stepped-care protocol to achieve a systolic/diastolic BP goal of <130/<80 mm Hg, with primary care physician supervision.

The researchers found that the net reductions in systolic and diastolic BP were 22.0 and 9.3 mm Hg, respectively, over 48 months in the intervention group compared with usual care. The intervention group had a significantly lower primary outcome of all-cause dementia than the usual care group (risk ratio, 0.85). The intervention group also had less frequent serious adverse events (risk ratio, 0.94).

"The effectiveness of BP reduction on the risk of dementia was consistent across subgroups based on age, sex, education, history of cigarette smoking, body mass index, systolic BP, fasting plasma glucose and 10-year atherosclerotic cardiovascular disease risk at baseline," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease

TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...

Overwork Tied to Structural Changes in Brains of Health Care Workers

MONDAY, May 19, 2025 -- Overwork in health care workers is associated with structural brain changes, particularly in regions linked to cognition and emotion, according to a study...

Greater Sedentary Time Associated With Higher Risk for Alzheimer Disease

FRIDAY, May 16, 2025 -- Sedentary time is associated with an increased risk for Alzheimer disease (AD), according to a study published online May 13 in Alzheimer's &...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.